Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

During the Trading Day
10.67 +0.06 / +0.57%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.67 -0.0021 / -0.02%
Volume: 36.2K
Health Technology

Company Description

BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in the pathogenesis of diseases with its focus on therapeutic areas with unmet medical needs. It integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company was founded in 1986 and is headquartered in Birmingham, AL.

Contact Information

BioCryst Pharmaceuticals, Inc.
4505 Emperor Boulevard
Durham North Carolina 27703-8457
P:(919) 859-1302
Investor Relations:
(919) 859-7910



Other institutional50.06%
Mutual fund holders39.88%
Individual stakeholders28.35%

Top Executives

Jon P. StonehousePresident, Chief Executive Officer & Director
Robert BennettVice President-Investor Relations & Operations
Thomas R. StaabChief Financial Officer, Treasurer, CAO & SVP
William P. SheridanChief Medical Officer & Senior Vice President
Lynne PowellChief Commercial Officer & Senior Vice President